STORY / PUBLIC SOURCE RECORD
New national export initiative: A shot in the arm for Norwegian health and life science
- Published 30 September 2024; updated 25 March 2026; estimated reading time 7 minutes. The article describes Norway’s national export initiative for health and life science, launched in 2024 under the government’s 2022 export reform. It lists 15 measures and presents public-private “Team Norway” coordination, joint marketing and brand-building as supports for international competitiveness. Innovation Norway implements some measures. The ambition cited is to help double industry export revenues; it is a goal, not an achieved result.
- The article profiles AdjuTec Pharma, founded in 2019, and its antibiotic-resistance “resistance breaker”: an enzyme inhibitor intended to restore the effect of existing antibiotics rather than create a new antibiotic. CEO Bjørn Klem says early tests, including animal trials, were promising; the article’s 2024-era account says healthy-volunteer tests were planned and estimates possible market readiness within five years. These are historical development plans, not current clinical status. Innovation Norway grants and Oslo Cancer Cluster support are cited.
- Kaass Discovery, led by physician/researcher Anita Kåss, was developing an AI-supported home device to collect health measurements and potentially anticipate changes such as MS attacks, while also developing treatments and other devices. The page says the company was pursuing a patent and had received EU funding through Eurostars and Women TechEU; no later market availability is established here.
- Connect the Dots (CTD) offers a VR medical-training tool for healthcare workers, with simulations such as a virtual patient whose condition deteriorates. CEO/co-founder Siva Snarby says it enables repeated practice where in-person training is constrained by cost and time. CTD had received Women TechEU funding and planned to grow in Norway before international expansion; the article cites potential uses from sepsis to COVID-19 and possible training/cost benefits as company expectations.
- Other linked examples include Zimmer & Peacock wearable biosensors, Decon-X automated disinfection and Bulbitech eye/neurological diagnostics. Direct contact blocks are not shown for the profiled companies. Related industry: Health and life science; several company solution pages are linked.